Raia Drogasil S.A. (RADLY)
USD 3.37
(-4.8%)
USD 3.37
(-4.8%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.08 Billion BRL | 40.58% |
| 2022 | 1.47 Billion BRL | 21.07% |
| 2021 | 1.22 Billion BRL | 43.1% |
| 2020 | 854.19 Million BRL | 8.8% |
| 2019 | 785.07 Million BRL | 8.81% |
| 2018 | 721.51 Million BRL | -8.97% |
| 2017 | 792.58 Million BRL | 12.34% |
| 2016 | 705.53 Million BRL | 694.65% |
| 2015 | 88.78 Million BRL | -71.28% |
| 2014 | 309.12 Million BRL | 106.31% |
| 2013 | 149.83 Million BRL | -6.72% |
| 2012 | 160.62 Million BRL | 101.9% |
| 2011 | 79.55 Million BRL | -29.11% |
| 2010 | 112.22 Million BRL | 15.93% |
| 2009 | 96.8 Million BRL | 102.2% |
| 2008 | 47.87 Million BRL | 105.08% |
| 2007 | 23.34 Million BRL | 186.87% |
| 2006 | -26.87 Million BRL | -312.67% |
| 2005 | 12.63 Million BRL | 47.4% |
| 2004 | 8.57 Million BRL | -5.75% |
| 2003 | 9.09 Million BRL | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 524.91 Million BRL | -38.96% |
| 2024 Q2 | 652.84 Million BRL | 25.06% |
| 2023 Q4 | 859.96 Million BRL | 104.43% |
| 2023 Q3 | 420.67 Million BRL | -25.28% |
| 2023 Q1 | 277.88 Million BRL | 40.95% |
| 2023 Q2 | 563.01 Million BRL | 102.61% |
| 2023 FY | 2.08 Billion BRL | 40.58% |
| 2022 Q4 | 197.15 Million BRL | -54.95% |
| 2022 Q1 | 183.65 Million BRL | -50.57% |
| 2022 Q2 | 560.1 Million BRL | 204.98% |
| 2022 FY | 1.47 Billion BRL | 21.07% |
| 2022 Q3 | 437.66 Million BRL | -21.86% |
| 2021 Q3 | 241.93 Million BRL | -41.29% |
| 2021 FY | 1.22 Billion BRL | 43.1% |
| 2021 Q4 | 371.5 Million BRL | 53.56% |
| 2021 Q1 | 287.71 Million BRL | 5.5% |
| 2021 Q2 | 412.07 Million BRL | 43.22% |
| 2020 Q1 | 234.19 Million BRL | 241.08% |
| 2020 Q2 | 104.09 Million BRL | -55.55% |
| 2020 Q4 | 272.72 Million BRL | -2.24% |
| 2020 FY | 854.19 Million BRL | 8.8% |
| 2020 Q3 | 278.97 Million BRL | 167.99% |
| 2019 Q3 | 167.98 Million BRL | -21.35% |
| 2019 FY | 785.07 Million BRL | 8.81% |
| 2019 Q1 | 101.08 Million BRL | -32.16% |
| 2019 Q2 | 213.59 Million BRL | 111.31% |
| 2019 Q4 | 68.66 Million BRL | -59.13% |
| 2018 Q1 | 176.14 Million BRL | -11.47% |
| 2018 FY | 721.51 Million BRL | -8.97% |
| 2018 Q4 | 148.99 Million BRL | -20.0% |
| 2018 Q3 | 186.23 Million BRL | -11.38% |
| 2018 Q2 | 210.14 Million BRL | 19.3% |
| 2017 Q1 | 164.33 Million BRL | 6.76% |
| 2017 Q4 | 198.96 Million BRL | -5.12% |
| 2017 FY | 792.58 Million BRL | 12.34% |
| 2017 Q3 | 209.7 Million BRL | -4.5% |
| 2017 Q2 | 219.57 Million BRL | 33.61% |
| 2016 Q4 | 153.92 Million BRL | -16.12% |
| 2016 FY | 705.53 Million BRL | 694.65% |
| 2016 Q1 | 129.9 Million BRL | 144.01% |
| 2016 Q3 | 183.5 Million BRL | -22.96% |
| 2016 Q2 | 238.2 Million BRL | 83.36% |
| 2015 FY | 88.78 Million BRL | -71.28% |
| 2015 Q2 | 161.58 Million BRL | 63.48% |
| 2015 Q4 | -295.19 Million BRL | -338.93% |
| 2015 Q3 | 123.54 Million BRL | -23.54% |
| 2015 Q1 | 98.84 Million BRL | 7.27% |
| 2014 FY | 309.12 Million BRL | 106.31% |
| 2014 Q1 | 42.32 Million BRL | 6.65% |
| 2014 Q2 | 85.75 Million BRL | 102.59% |
| 2014 Q3 | 88.89 Million BRL | 3.66% |
| 2014 Q4 | 92.14 Million BRL | 3.66% |
| 2013 Q4 | 39.69 Million BRL | 34.96% |
| 2013 FY | 149.83 Million BRL | -6.72% |
| 2013 Q3 | 29.4 Million BRL | -47.8% |
| 2013 Q2 | 56.33 Million BRL | 130.87% |
| 2013 Q1 | 24.4 Million BRL | 3.94% |
| 2012 Q1 | 24.21 Million BRL | 414.34% |
| 2012 FY | 160.62 Million BRL | 101.9% |
| 2012 Q4 | 23.47 Million BRL | -48.73% |
| 2012 Q3 | 45.79 Million BRL | -31.8% |
| 2012 Q2 | 67.14 Million BRL | 177.28% |
| 2011 FY | 79.55 Million BRL | -29.11% |
| 2011 Q3 | 28.85 Million BRL | -15.86% |
| 2011 Q2 | 34.29 Million BRL | 241.54% |
| 2011 Q1 | 10.04 Million BRL | -49.46% |
| 2011 Q4 | 4.7 Million BRL | -83.68% |
| 2010 Q1 | -7.98 Million BRL | -144.97% |
| 2010 FY | 112.22 Million BRL | 15.93% |
| 2010 Q4 | 19.86 Million BRL | -34.24% |
| 2010 Q3 | 30.21 Million BRL | 7.77% |
| 2010 Q2 | 28.03 Million BRL | 451.27% |
| 2009 FY | 96.8 Million BRL | 102.2% |
| 2009 Q4 | 17.74 Million BRL | -39.26% |
| 2009 Q3 | 29.21 Million BRL | 24.34% |
| 2009 Q2 | 23.49 Million BRL | 479.11% |
| 2009 Q1 | -6.19 Million BRL | 0.0% |
| 2008 FY | 47.87 Million BRL | 105.08% |
| 2007 FY | 23.34 Million BRL | 186.87% |
| 2006 FY | -26.87 Million BRL | -312.67% |
| 2005 FY | 12.63 Million BRL | 47.4% |
| 2004 FY | 8.57 Million BRL | -5.75% |
| 2003 FY | 9.09 Million BRL | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -261.11 USD | 796786511.857% |
| Allstar Health Brands, Inc. | -215.75 Thousand USD | 964405.446% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million USD | -233.332% |
| Café Serendipity Holdings, Inc. | -1.43 Million USD | 145072.315% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -47.57 Thousand USD | 4373631.638% |
| HealthWarehouse.com, Inc. | -1.62 Million USD | 128392.203% |
| LIGAND PHARMACEUTICAL INC | 9.82 Million USD | -21084.085% |
| MedGen, Inc. | -15.54 USD | 13387960202.96% |
| Omni Health, Inc. | 405.52 Thousand USD | -512942.267% |
| Oxford Investments Holdings Inc. | -342.3 Thousand USD | 607891.635% |
| Pineapple, Inc. | -1.47 Million USD | 140898.478% |
| ScripsAmerica, Inc. | -3.8 Million USD | 54744.678% |